Eli Lilly & Co. (LLY)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Eli Lilly & Co. (LLY)
Company Performance

Current Price

as of Nov 22, 2024

$748.01

P/E Ratio

81.83

Market Cap

$710.1B

Loading...
Description

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Metrics

Overview

  • HQIndianapolis, IN
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerLLY
  • Price$748.01-0.25%

Trading Information

  • Market cap$710.10B
  • Float89.61%
  • Average Daily Volume (1m)5,623,799
  • Average Daily Volume (3m)3,441,646
  • EPS$9.17

Company

  • Revenue$40.86B
  • Rev growth (1yr)20.43%
  • Net income$970.30M
  • Gross margin81.02%
  • EBITDA margin42.85%
  • EBITDA$4.90B
  • EV$829.46B
  • EV/Revenue20.30
  • P/E81.83
  • P/S16.57
  • P/B49.91
Documents
Factset Street Account